The goal of the trial was to evaluate treatment with the acyl coenzyme A: cholesterol acyltransferase inhibitor (ACAT) pactimibe compared with placebo in patients with familial hypercholesterolemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results